Back to PharmOncology

Podcast Episode

Why current HER2 testing is flawed

PharmOncology··16 August 2026·12 min

About this episode

Problems with how we currently test for HER2 and possible future directions. Trastuzumab in endometrial cancer: https://pmc.ncbi.nlm.nih.gov/articles/PMC8792803/Issues with HER2 testing in endometrial cancer: https://www.gynecologiconcology-online.net/article/S0090-8258(25)01072-8/fulltexthttps://www.mdpi.com/2072-6694/18/12/2009Novel methods of testing for HER2: https://www.nature.com/articles/s41698-026-01365-6